share_log

三生国健:监事会关于公司2024年限制性股票激励计划(草案)的核查意见

Sunshine Guojian Pharmaceutical: Supervisory Board's verification opinion on the company's 2024 Restricted Stock Incentive Plan (Draft).

SZSI ·  Jun 5
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more